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To the Editor: 
We read with great interest and concern the paper by LeMay and 
colleagues regarding the role of radial approach in patients with acute coronary 
syndrome (ACS). Our concerns are due to LeMay’s inappropriate interpretation 
of clinical trial data and spurious arguments against radial access that runs of the 
risk of slowing the adoption of transradial procedures and thus potentially lead to 
increased adverse outcomes among high-risk patients undergoing PCI.   
LeMay’s concerns over multiple comparisons in the MATRIX trial are 
unfounded. While there are several techniques to account for multiple 
comparisons, the Bonferroni-Holm correction, which was pre-specified in the 
MATRIX trial (1), is by far the most conservative one. In the MATRIX trial, radial 
approach significantly reduced the incidence of 30-day NACE (p=0.009). These 
results are robust even when accounting for 4 comparisons. In addition, many of 
the large seminal trials of acute coronary syndromes have included both NSTEMI 
and STEMI patients (2),(3).  The correct interpretation of subgroups is to use 
interaction p-value to determine consistency of benefit in subgroups and the 
benefit was consistent in both NSTEMI and STEMI in MATRIX. Taken together, 
the available trials strongly demonstrate that TRI is superior to femoral approach 
in ACS patients regardless of presentation. Regarding the effect of center 
volume, the beneficial effect of radial approach was more pronounced at centers 
with high radial volume (i.e. a greater proportion of procedures performed via 
radial access) in the RIVAL and MATRIX trials. The positive interaction term by 
center volume demonstrates that the primary effect may be affected to some 
degree by the subgroup – in other words, the results of the MATRIX trial stand 
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alone and the finding in the subgroups of center radial volume demonstrate that 
centers that perform a high proportion of TRI realize its greater benefits – a 
finding that is completely consistent with the volume-outcome relationship for 
cardiovascular procedures. There was no significant difference in the use of 
glycoprotein IIb/IIIa inhibitors (GPI) between the radial and femoral groups in the 
MATRIX trial, and the benefit of radial access was irrespective of GPI use. 
Finally, a commonly held belief among interventional cardiologists is that VCDs 
reduce bleeding, and LeMay and colleagues repeat this misconception in their 
review. A meta-analysis of randomized trials showed that VCDs were no better 
than manual compression at preventing vascular complications and may 
increase the risk of groin hematoma and pseudoaneurysm (4). The ISAR-
CLOSURE trial showed that VCDs were noninferior, not superior, to manual 
compression with respect to 30-day vascular complications (5). The added cost 
of VCDs are not justified when their outcomes are either no better or worse than 
manual compression.  
The randomized trial data clearly support the use of radial access in 
patients with acute coronary syndromes undergoing angiography or intervention.  
Given the robustness of the data, performing more randomized trials, like the 
SAFARI STEMI trial, which is one-third the size of the MATRIX trial and is most 
likely underpowered for the primary outcome, is unlikely to be informative. 
Instead, effort should be directed at increasing the adoption of radial approach 
and ensuring proficiency with the procedure using “best practices” as the 
foundation (6).  
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